Blockchain Registration Transaction Record

Quantum BioPharma Receives Approval for Phase 2 Clinical Trial of FSD202 for Chronic Pain Associated with MCAS

Quantum BioPharma (NASDAQ: QNTM) receives approval for Phase 2 clinical trial of FSD202, a potential treatment for chronic pain associated with MCAS. The trial aims to measure pain reduction over 56 days, offering hope for patients with this debilitating disorder.

This news matters as it highlights a significant step forward in the development of a potential treatment for chronic pain related to MCAS, providing hope for patients with this challenging disorder. The approval of the Phase 2 trial underscores the commitment of Quantum BioPharma to address the unmet medical needs of those suffering from musculoskeletal nociplastic pain.

Blockchain	Details
Contract Address	0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID	0xb2b56deddb4bf535d3ebdf5d2fc24d966de0743b94d9bedc5500713941916369
Account	0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chain	polygon-main
NewsRamp Digital Fingerprint	deepc5Yu-33b33becab9e9996f05ccccf5ff1c151

What is Blockchain Registration?

NewsRamp is at the forefront of transforming news integrity for partner newswires. Our exclusive service harnesses the power of blockchain technology to register press releases, ensuring that every piece of news delivered to you remains authentic and unaltered from its initial release. By collaborating with leading newswires, we offer a unique verification service that anchors each press release in a tamper-proof digital record. This blockchain-based approach not only enhances the transparency of news dissemination but also strengthens trust between our partner newswires, their clients, and readers worldwide.

With NewsRamp, the Source of Truth for press releases shifts to the blockchain, providing an immutable guarantee of authenticity. This innovation elevates the standard for news reliability, offering peace of mind to readers that the news they engage with is exactly as it was originally published. Trust in the transparency and integrity of news has never been more critical, and NewsRamp is proud to lead this charge, ensuring that our partner newswires can offer their audiences nothing but verified, unaltered news. Welcome to the new era of press release distribution – powered by NewsRamp, where we bridge technology and trust for the ultimate in news verification.